Myopic macular neovascularization
Myopic macular neovascularization (MNV) located in the superior parafoveal region can be effectively treated with anti-VEGF therapy. After treatment, the lesion appears as an area of hypoautofluorescence on fundus autofluorescence (FAF), indicating resolution of neovascular activity and associated damage to the retinal pigment epithelium (RPE). FAF is a useful tool for monitoring post-treatment changes. #MyopicMNV #AntiVEGF #FAF…
Aneurysmal type 1 MNV
A 76-year-old male presented with subretinal fluid involving the macula. Careful analysis of OCT and OCTA revealed the condition to be aneurysmal type 1 MNV (polypoidal choroidal vasculopathy). Following a loading dose of anti-VEGF treatment, there was resolution of the fluid and significant improvement of the fibrovascular PED. #MNV #PolypoidalChoroidalVasculopathy #AntiVEGF #SubretinalFluid #OCT #OCTA #retina #oftalmo #ophthalmology…
PDR: Persistent neovessels
Proliferative diabetic retinopathy (PDR) with persistent neovessels despite panretinal photocoagulation (PRP) and anti-VEGF treatment poses a significant challenge. Continuous neovascularization indicates aggressive disease and may require additional or alternative therapeutic approaches, such as surgical intervention like vitrectomy to manage complications and preserve vision. #PDR #PersistentNeovessels #PRP #AntiVEGF #DiabeticRetinopathy…
Ricardo Leitão Guerra
Yudisthra
